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Abstract
Endocytosis of tyrosine kinase receptors can influence both the duration and the specificity of the signal emitted. We have
investigated the mechanisms of internalization of fibroblast growth factor receptor 3 (FGFR3) and compared it to that of
FGFR1 which is internalized predominantly through clathrin-mediated endocytosis. Interestingly, we observed that FGFR3
was internalized at a slower rate than FGFR1 indicating that it may use a different endocytic mechanism than FGFR1. Indeed,
after depletion of cells for clathrin, internalization of FGFR3 was only partly inhibited while endocytosis of FGFR1 was almost
completely abolished. Similarly, expression of dominant negative mutants of dynamin resulted in partial inhibition of the
endocytosis of FGFR3 whereas internalization of FGFR1 was blocked. Interfering with proposed regulators of clathrin-
independent endocytosis such as Arf6, flotillin 1 and 2 and Cdc42 did not affect the endocytosis of FGFR1 or FGFR3.
Furthermore, depletion of clathrin decreased the degradation of FGFR1 resulting in sustained signalling. In the case of
FGFR3, both the degradation and the signalling were only slightly affected by clathrin depletion. The data indicate that
clathrin-mediated endocytosis is required for efficient internalization and downregulation of FGFR1 while FGFR3, however,
is internalized by both clathrin-dependent and clathrin-independent mechanisms.
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Introduction
Signalling from receptors at the cell surface is regulated by
endocytosis. For instance, signalling from many receptors is termi-
nated by internalization and degradation in lysosomes. Further-
more, an endosomal location can allow the receptors to recruit
and activate downstream signalling molecules different from the
cell surface receptors [1–3]. Thus, internalization is an important
step which can influence the duration of signalling as well as the
specificity of signalling targets.
Several pathways of internalization that differ in the required
protein machinery have been described. The best studied endo-
cytic mechanism is characterized by the formation of clathrin
coated pits at the plasma membrane. The pits pinch off from the
cell surface by the large GTPase dynamin. Internalization of many
receptors such as the transferrin (Tf) receptor and the epidermal
growth factor receptor (EGFR) are mainly clathrin dependent [4–
6]. However, clathrin-mediated internalization of EGFR seems to
vary with the conditions. Under conditions of moderate expres-
sion, the EGFR are predominantly internalized through clathrin-
mediated endocytosis. Under conditions of overexpression of
EGFR or high ligand concentrations, the receptor is internalized
through both clathrin-mediated and non-clathrin endocytosis [7].
The clathrin-independent mechanisms of internalization are
less well understood than the clathrin-dependent mechanism. A
classification of the different clathrin-independent mechanisms
into five potential subgroups has been proposed: caveolar, IL2-
receptor, GEEC/CLIC, Arf6, and flotillin endocytic pathway
[8,9]. Two of them, the IL2-receptor and the caveolar uptake
require dynamin [8]. Several other small GTPases have also been
associated with the different clathrin-independent pathways, such
as Cdc42 with the GEEC/CLIC pathway. However, the number
and molecular identity of clathrin-independent endocytic mech-
anisms are still not clear and the identification of more specific
markers and cargo molecules are needed to allow a definitive
dissection of the clathrin-independent endocytic pathways [10–
12].
It has been suggested that the route of internalization can
determine whether signalling receptors are degraded or recycled,
and whether or not they initiate signalling from endosomes. It has
been proposed that EGFRs internalized via a clathrin-dependent
pathway are recycled back to the cell surface whereas EGFRs
internalized independently of clathrin are efficiently degraded
[13]. Similarly, TGF-b receptors internalized via caveolae are
sorted to degradation, whereas those internalized via clathrin-
coated pits are directed to an endosomal compartment associated
with accessory proteins which promote signal transduction [14,
15]. In this way, the many endocytic pathways are not solely
different mechanisms for internalization but can also dictate the
further signalling and intracellular trafficking of their cargo.
PLoS ONE | www.plosone.org 1 July 2011 | Volume 6 | Issue 7 | e21708The fibroblast growth factor receptor (FGFR) family consists of
four tyrosine kinase receptors designated FGFR1-4. Upon ligand
binding the receptors are autophosphorylated and activate several
signalling pathways such as the Ras/MAPK (mitogen-activated
protein kinase), phosphoinositide 3-kinase/Akt and PLC-c (phos-
pholipase C-c)/protein kinase C [16]. Depending on the target cell
type, FGFR signalling can induce cell proliferation, differentiation,
apoptosis and cell motility. Deregulation of FGFR signalling has
been associated with a number of serious disorders such as cancer
and several forms of dwarfism [17–19].
The signalling mechanisms of FGFRs have been extensively
studied but the internalization pathways, however, are not entirely
clear. We and others have found that endocytosis of FGFR1
depends on clathrin [20,21]. Moreover, a splice variant of FGFR2
called FGFR2b or keratinocyte growth factor receptor (KGFR)
was demonstrated to localize to clathrin coated pits and later on, it
was reported that depletion of clathrin inhibited KGFR endo-
cytosis [22,23]. A few studies describe endocytic trafficking and
sorting of FGFR3 but the machinery responsible for FGFR3
internalization remains to be elucidated [24,25]. Since deregulated
FGFR3 signalling is involved in a variety of skeletal disorders as
well as in certain malignancies, it is important to elucidate how
FGFR3 signalling is regulated. Here we characterize the molecular
machinery involved in endocytosis of FGFR3 and further examine
how internalization influences FGFR signalling.
Results
Internalization of FGF1 by FGFR1 and FGFR3 in cells
depleted of clathrin heavy chain
In a recent paper we reported that FGF1 is internalized
predominantly via clathrin-mediated endocytosis in U2OS cells
stably transfected with FGFR1 [20]. In order to characterize the
internalization of FGFR3, we generated U2OS cells stably ex-
pressing FGFR3. This made it possible to compare the inter-
nalization of FGFR3 to that of FGFR1 in the same cellular system
and under approximately similar conditions. FGF1 is assumed to
bind similarly well to FGFR1 and FGFR3 [26].
To exclude the possibility that U2OS cells express endogenous
FGFRs that could interfere with the experimental setup, untrans-
fected U2OS cells or U2OS cells stably expressing FGFR1 or
FGFR3 were allowed to internalize Cy3-FGF1 for 20 minutes
before fixation and examination in a confocal microscope. Cy3-
FGF1 was not detected in untransfected U2OS cells as opposed to
U2OS cells stably expressing FGFR1 or FGFR3 (Fig. 1A). More-
over, we were not able to detect any of the four FGFRs in
untransfected U2OS cells by Western blotting (Fig. S1). These
data indicate that the U2OS cells do not express detectable levels
of any of the four FGFRs endogenously.
First, we compared the endocytic uptake of
125I-FGF1 in cells
stably expressing FGFR1 or FGFR3. We noticed that the uptake
of FGFR3 was significantly slower than that of FGFR1 (Fig. 1B).
The rate of FGF1 internalization was measured as the ratio of
endocytosed to surface bound
125I-FGF1 at different time points
and the slope in Fig 1B for FGFR1 cells is 0.0648 and 0.0283 for
FGFR3 cells. The different kinetics for FGF1 uptake via FGFR3
compared to FGFR1 indicates that different endocytic mecha-
nisms might be involved.
Thus, to test whether endocytosis of FGF1 in FGFR3 cells is
mediated by clathrin, U2OS cells stably expressing FGFR3 or
FGFR1 (as a control) were transfected with vector-based siRNA
against clathrin heavy chain (CHC). The cells were then allowed
to internalize Cy3-FGF1 and Alexa 647-Tf for 20 min and the
cells were fixed and stained with anti-CHC antibody. Subsequently,
the cells were examined in a confocal microscope. Cells with
efficient knockdown of clathrin were identified based on their low
level of anti-CHC antibody staining and their inability to internalize
Alexa 647-Tf. In FGFR1 cells depleted of clathrin, little Cy3-FGF1
could be detected inside the cells and a Cy3-FGF1 pattern which
resemblescell surfacestaining wasobserved(Fig.1C).Thisprobably
represents FGF1 bound to receptors at the cell surface indicating
that internalization of FGFR1 is indeed dependent on clathrin.
Interestingly, in FGFR3 cells depleted of clathrin, Cy3-FGF1 was
clearly still internalized. Also in these cells, the uptake of Alexa 647-
Tf was blocked indicating an efficient knockdown of CHC.
The intensity of Cy3-FGF1 staining in cells depleted of clathrin
was quantified and compared to the intensity of Cy3-FGF1 staining
in cells with normal clathrin levels. In FGFR1 cells depleted of
clathrin, the uptake of FGF1 was reduced to about 4% compared to
non-depleted cells whereas the uptake of FGF1 in FGFR3 cells
depleted of clathrin was only reduced to approximately 40%
compared to non-depleted cells (Fig. 1D). These results confirm that
FGFR1 is internalized predominantly via clathrin-mediated endo-
cytosis and they demonstrate that endocytosis of FGFR3 is only
partly dependent on clathrin.
Similar results were also obtained using another siRNA ap-
proach. Cells were depleted of clathrin using a specific oligo-based
siRNA against CHC [6] and then the rate of FGF1 internalization
was examined in cells expressing FGFR1 or FGFR3 and measured
as the ratio of endocytosed to surface bound
125I-FGF1 at different
time points. Efficient knockdown of clathrin was confirmed by
Western blotting (Fig. 1E). The rate of endocytosis of FGF1 in
FGFR1 cells depleted of clathrin was significantly reduced com-
pared to cells with intact clathrin levels (Fig. 1F). The slope in
Figure 1F for FGFR1 cells was reduced from 0.0761 in FGFR1
cells transfected with scrambled siRNA to 0.0267 in FGFR1 cells
depleted of clathrin. This is in agreement with our previous
findings [20]. The rate of endocytosis of FGF1 in FGFR3 cells
depleted of clathrin was only partly reduced compared to cells with
intact clathrin levels. The slope in Figure 1F was reduced from
0.0275 in scrambled siRNA transfected FGFR3 cells to 0.0197 in
FGFR3 cells depleted of clathrin. The experiment was repeated in
three different clones of U2OS cells stably expressing FGFR3 with
similar results (data not shown). Moreover, CHC knockdown did
not interfere with the number of receptors at the cell surface at
steady state measured as
125I-FGF1 bound to the cells (Fig. S2A).
Also, the uptake of
125I-Tf was reduced to a similar extent in
U2OS cells stably expressing FGFR1 or FGFR3 upon clathrin
depletion (Fig. S2B).
Sigismund et al. [27] reported that EGFR is internalized
through clathrin-mediated endocytosis and non-clathrin endocy-
tosis dependent on ligand dose. We therefore investigated if
clathrin-mediated endocytosis of FGFR1 and FGFR3 could also
be dependent on ligand dose. Saturation binding experiments
demonstrated that concentrations of
125I-FGF1above 20–30 ng/ml
were saturating in both cell lines (Fig. S3). Therefore, we used
2 ng/ml, 20 ng/ml and 100 ng/ml
125I-FGF1 to test if high
(100 ng/ml) and low (2 ng/ml) concentrations of FGF1 affect the
clathrin-mediated endocytic uptake via FGFR1 and FGFR3. The
cells were depleted of clathrin using siRNA oligos and the ratio of
internalized to surface bound
125I-FGF1 at different time points
was examined. As can be seen in Fig. 2, the knockdown of CHC
reduced the rate of endocytosis of FGF1 to the same extent whether
high or low concentrations of
125I-FGF1 were used. This is in
agreement with the data presented in Fig. 1 since we used low
concentrations of
125I-FGF1 to investigate the rate of endocytosis in
clathrin knockdown cells whereas high concentrations of Cy3-
FGF1 was used in the confocal experiments. In both cases,
Endocytosis of FGFR3
PLoS ONE | www.plosone.org 2 July 2011 | Volume 6 | Issue 7 | e21708Figure 1. The effect of clathrin heavy chain depletion on endocytosis of FGF1 in cells expressing FGFR1 or FGFR3. (A) Untransfected
U2OS cells or U2OS cells stably expressing FGFR1 or FGFR3 were incubated for 20 minutes at 37uC with Cy3-FGF1 and 50 U/ml heparin. The cells were
stained with Hoechst 33342 and examined with confocal microscopy. Bar, 5 mm. (B) U2OS cells stably expressing FGFR1 or FGFR3 were grown on
gelatinized plates and incubated with 10 ng/ml
125I-FGF1, 20 U/ml heparin and 0.2% gelatine at 37uC for indicated periods of time. Internalized and
surface-bound
125I-FGF1 were separated as described in Materials and methods and the ratio was plotted as function of time. The graph represents
the mean 6s.d. of three independent experiments with three parallels. (B) U2OS cells stably expressing FGFR1 or FGFR3 were subjected to vector-
based siRNA against CHC for 4 days to knock down clathrin. The cells were then incubated for 20 minutes at 37uC with Cy3-FGF1, Alexa 647-Tf and
50 U/ml heparin. The cells were stained with goat anti-CHC antibody and examined with confocal microscopy. Bar, 5 mm. (C) The uptake of Cy3-FGF1
was measured as Cy3 intensity in non-depleted and CHC depleted cells treated as described in B. Only cells in which Tf uptake was inhibited were
defined as depleted of CHC. The mean intensity of Cy3 in CHC depleted cells is presented in the histogram as the percentage of Cy3 intensity in non-
depleted cells. The histogram represents the mean +s.d. of three independent experiments and 15-45 cells were quantified in each case in each
experiment. Confocal scanning was performed with identical settings. (D) U2OS cells stably expressing FGFR1 or FGFR3 were transfected with siRNA
oligos (100 nM) targeting CHC or a non-targeting siRNA control (scr) as described in Materials and Methods. The level of knockdown was assessed in
every experiment by Western blotting using mouse anti-CHC antibody. Anti-Hsp90 antibody was used as a loading control. One representative
Western blot is shown. (E) U2OS cells stably expressing FGFR1 or FGFR3 were transfected with siRNA oligos (100 nM) targeting CHC or a non-
targeting siRNA control (scr), grown on gelatinized plates and incubated with 10 ng/ml
125I-FGF1, 20 U/ml heparin and 0.2% gelatine at 37uC for
indicated periods of time. Internalized and surface-bound
125I-FGF1 were separated as described in Materials and Methods and the ratio was plotted
as function of time. Note the different scale on the Y axis. The graph represents the mean 6s.d. of three independent experiments with three
parallels.
doi:10.1371/journal.pone.0021708.g001
Endocytosis of FGFR3
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of FGFR3 was only partly dependent on clathrin.
Role of dynamin in internalization of FGF1 by FGFR1 and
FGFR3
Many of the endocytic pathways described to date, including
clathrin mediated endocytosis, are dependent on the small
GTPase dynamin. To test if endocytosis of FGF1 via FGFR3 is
dependent on dynamin, U2OS cells stably expressing FGFR3 or
FGFR1 (as a control) were transfected with either wild-type
dynamin 1 or 2 or a dominant negative mutant of dynamin 1 or 2
(dynamin 1 K44A or dynamin 2 K44A) [28,29]. The transfected
cells were allowed to endocytose Cy3-FGF1 for 20 minutes and
then the cells were fixed and analysed by confocal microscopy.
The data in Fig. 3A and B demonstrate the presence of in-
tracellular vesicles containing endocytosed Cy3-FGF1 in FGFR1
and in FGFR3 cells expressing wild-type dynamin 1 or 2. In cells
expressing the dominant negative constructs of dynamin, the
pattern of Cy3-FGF1 was changed. In transfected FGFR1 cells,
Cy3-FGF1 was now hardly detectable inside the cells indicating
that internalization of FGFR1 is dependent on dynamin. In
transfected FGFR3 cells, Cy3-FGF1 was distributed in dots. A
similar pattern was observed in three different clones of U2OS
cells stably expressing FGFR3 (data not shown).
Next, we studied if the dots of Cy3-FGF1 in FGFR3 cells
expressing the dominant negative dynamin were indeed vesicles
containing Cy3-FGF1 or, alternatively, if they were enrichments of
Cy3-FGF1 in distinct areas at the cell-surface. For this purpose,
FGFR1 and FGFR3 cells transfected with dynamin 1 K44A and
incubated with Cy3-FGF1 were either left untreated or washed
with high salt, low pH buffer (HSLP) to remove surface bound
Cy3-FGF1 [30]. Resistance to HSLP-wash indicates intracellular
localization of Cy3-FGF1. The weak Cy3-FGF1 staining in Fig. 4A
(upper panel) disappeared upon washing with HSLP-buffer (lower
panel) indicating that no Cy3-FGF1 was internalized in FGFR1
cells expressing the dominant negative dynamin. However, in
FGFR3 cells expressing the dominant negative dynamin, several
Cy3-FGF1 dots were observed (Fig. 4B, upper panel). Even
though washing with HSLP clearly reduced the number of Cy3-
FGF1 dots, many dots were still visible in the FGFR3 cells upon
HSLP-wash (lower panel).
To test if the dots observed in FGFR3, dynamin 1 K44A
expressing cells are really intracellular vesicles and not pits at the
cell-surface that are protected from the extracellular milieu, the
cells were also stained with anti-EEA1 antibody. EEA1 is a protein
associated with early/sorting endosomes. Thus, colocalization of
Cy3-FGF1 and EEA1 indicates that the Cy3-FGF1 dots are
vesicles inside the cell. As expected, in the case of FGFR1 there
was no colocalization of the weak Cy3-FGF1 pattern and EEA1
(Fig. 4A). On the other hand, many of the Cy3-FGF1 dots in
FGFR3 cells expressing the dominant negative dynamin coloca-
lized with EEA1 in unwashed cells. In HSLP treated cells, there
Figure 2. The effect of low and high concentrations of FGF1 on endocytosis in cells expressing FGFR1 or FGFR3 and depleted of
clathrin heavy chain. U2OS cells stably expressing FGFR1 (A) or FGFR3 (B) were transfected with siRNA oligos (100 nM) targeting CHC or a non-
targeting siRNA control (scr), grown on gelatinized plates and incubated with 2, 20 or 100 ng/ml
125I-FGF1, 20 U/ml heparin and 0.2% gelatine at
37uC for indicated times. Internalized and surface-bound
125I-FGF1 were separated as described in Materials and Methods and the ratio was plotted as
function of time. Note the different scale on the Y axis. The graph represents one independent experiment with three parallels 6s.d.
doi:10.1371/journal.pone.0021708.g002
Endocytosis of FGFR3
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(Fig. 4B, see enlarged areas to the right).
These results were further supported by quantifying the inten-
sity of Cy3-FGF1 staining in cells expressing dynamin 1 K44A and
comparing it to the intensity of the Cy3-FGF1 staining in non-
expressing cells. The cells were washed with HSLP-buffer before
fixation to remove surface-bound Cy3-FGF1. In FGFR1 cells
expressing dynamin 1 K44A, the uptake of FGF1 was reduced to
about 10% compared to nonexpressing cells. In the FGFR3 cells
expressing dynamin 1 K44A the uptake of FGF1 was reduced to
only 50% compared to nonexpressing cells (Fig. 4C). Taken
together, this indicates that in FGFR3 cells expressing dynamin 1
K44A some of the Cy3-FGF1 is internalized into vesicles whereas
some of the Cy3-FGF1 appears to be enriched in distinct areas at
the cell surface. Thus, endocytosis of FGF1 via FGFR3 seems to
be only partly dependent on dynamin.
Role of clathrin-independent endocytic regulators in
internalization of FGF1 by FGFR1 and FGFR3
As Arf6 and Cdc42 have been suggested to regulate two distinct
clathrin- and dynamin-independent pathways, we tested whether
these GTPases play a role in FGFR3 endocytosis. U2OS cells
stably expressing FGFR1 or FGFR3 were transfected with do-
minant negative mutants of Arf6 (Arf6 T27N) or Cdc42 (Cdc42
N17). The cells were then allowed to endocytose Cy3-FGF1 for 20
minutes before fixation and analysis by confocal microscopy. Cy3-
FGF1 was efficiently internalized in transfected and untransfected
FGFR1 and FGFR3 cells in both cases (Fig. 5A). Quantification of
the intensity of Cy3-FGF1 staining in cells expressing the mutants
compared with nonexpressing cells revealed that the Cy3-FGF1
uptake was not significantly changed in either case (Fig. 5B). Also,
siRNAs directed against Arf6 or Cdc42 were used to elucidate
their role in FGFR3 endocytosis. Despite an apparently efficient
knockdown of Arf6 and Cdc42 (Fig. 5C,E and Fig. S4), the rate of
endocytosis of
125I-FGF1 in depleted FGFR1 or FGFR3 cells was
not significantly changed in either case (Fig. 5D,F). Taken
together, the data indicate that neither Arf6 nor Cdc42 are major
players in FGFR1 or FGFR3 endocytosis in these cells.
In the absence of an effect of perturbed Arf6 or Cdc42 activity
in FGFR endocytosis, we chose to test the efficacy of disruption in
cell migration assays, since both Cdc42 and Arf6 are known to
play important roles in this process [31–34]. Using the same
conditions as in the endocytosis experiments, we observed that
disruption of Cdc42 and Arf6 led to reduced velocity of migrating
cells compared to control cells (Fig. S5A,B). This finding indicates
that the conditions used above significantly disrupt Arf6 and
Cdc42 function.
Flotillin 1 and 2 (reggie 2 and reggie 1, respectively), have also
been implicated in clathrin-independent endocytosis. In order to
elucidate their role in FGFR3 endocytosis, siRNA oligos directed
Figure 3. The effect of dynamin 1, dynamin 1 K44A, dynamin 2 or dynamin 2 K44A expression on FGF1 internalization. U2OS cells
stably transfected with FGFR1 (A) or FGFR3 (B) were transfected with HA-tagged dynamin constructs as indicated and incubated with Cy3-FGF1 and
50 U/ml heparin at 37uC for 20 min. The cells were then fixed and stained with anti-HA antibody. The cells were examined with confocal microscopy.
Bar, 5 mm.
doi:10.1371/journal.pone.0021708.g003
Endocytosis of FGFR3
PLoS ONE | www.plosone.org 5 July 2011 | Volume 6 | Issue 7 | e21708Figure 4. Localization of FGF1 in FGFR1 or FGFR3 cells expressing dynamin 1 K44A. U2OS cells stably transfected with FGFR1 (A) or FGFR3
(B) were transfected with HA-tagged dynamin 1 K44A and incubated with Cy3-FGF1 and 50 U/ml heparin at 37uC for 20 min. The cells were then fixed
and stained with anti-HA and anti-EEA1 antibodies. In some cases the cells were washed with high salt/low pH buffer (HSLP) to remove surface-bound
Cy3-FGF1 before fixation. The cells were examined with confocal microscopy. Arrows point to cells transfected with dynamin 1 K44A. Selected areas are
enlarged and shown at the right side. Bar, 5 mm. (C) The uptake of Cy3-FGF1 was measured as Cy3 intensity in untransfected and dynamin 1 K44A
transfected cells. All cells were washed with HSLP-buffer to remove cell-surface bound Cy3-FGF1. The mean intensity of Cy3 in dynamin 1 K44A
transfectedcellsispresentedinthehistogramasthepercentageofCy3intensityinuntransfectedcells.Thehistogramrepresentsthemean+s.d.ofthree
independent experiments and 20–60 cells were quantified in each case in each experiment. Confocal scanning was performed with identical settings.
doi:10.1371/journal.pone.0021708.g004
Endocytosis of FGFR3
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FGFR1 or FGFR3 cells. Knockdown efficiency was examined by
Western blotting and qRT-PCR (Fig. 6A and Fig S4). The
transfected cells were allowed to endocytose Cy3-FGF1 for 20
minutes and then the cells were fixed, stained with anti-flotillin 1
antibody or anti-flotillin 2 antibody and analysed by confocal
microscopy (Fig. 6B). The staining of the flotillins was hardly
visible in the cytoplasm in the siRNA transfected cells confirming
the efficient knockdown. However, some anti-flotillin 2 antibody
staining could be detected in the nucleus of cells even after efficient
knockdown of the protein probably representing unspecific anti-
body-staining. Recently, we performed knockdown of flotillin 1
Figure 5. The effect of Arf6 and Cdc42 on endocytosis of FGF1 in cells expressing FGFR1 or FGFR3. (A) U2OS cells stably transfected
with FGFR1 or FGFR3 were transfected with HA-tagged Arf6 T27N or EGFP-Cdc42 N17 and incubated with Cy3-FGF1 and 50 U/ml heparin at 37uC for
20 min. The cells were then fixed and examined with confocal microscopy. Cells transfected with Arf6 T27N were stained with anti-HA antibody. Bar,
5 mm. (B) The uptake of Cy3-FGF1 was measured as Cy3 intensity in untransfected or Arf6 T27N or Cdc42 N17 transfected cells. The mean intensities
of Cy3 in transfected cells are presented in the histograms as the percentage of Cy3 intensity in untransfected cells. The histogram represents the
mean +s.d. of three independent experiments and 15–55 cells were quantified in each case in each experiment. Confocal scanning was performed
with identical settings. U2OS cells stably expressing FGFR1 or FGFR3 were transfected with siRNA oligos (25 nM) targeting Arf6 (C) or Cdc42 (E)o ra
non-targeting siRNA control (scr) as described in Materials and Methods. The level of knockdown was assessed by Western blotting using rabbit anti-
Arf6 antibody or rabbit anti-Cdc42 antibody. Anti-Hsp90 antibody was used as a loading control. One representative Western blot is shown. Western
blots were quantified and the bands corresponding to Arf6 and Cdc42 were normalized to loading control and knockdown efficiency presented in
the histogram as percentage of non-targeting siRNA control (scr). The histogram represents the mean +s.d. of three independent experiments. U2OS
cells stably expressing FGFR1 or FGFR3 were transfected with siRNA oligos (25 nM) targeting Arf6 (D) or Cdc42 (F) or a non-targeting siRNA control
(scr), grown on gelatinized plates and incubated with 10 ng/ml
125I-FGF1, 20 U/ml heparin and 0.2% gelatine at 37uC for indicated periods of time.
Internalized and surface-bound
125I-FGF1 were separated as described in Materials and Methods and the ratio was plotted as function of time. Note
the different scale on the Y axis. The graph represents the mean 6s.d. of three independent experiments with three parallels.
doi:10.1371/journal.pone.0021708.g005
Endocytosis of FGFR3
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the retrograde transport of Shiga and Ricin toxin [35]. However,
here despite an efficient knockdown, we did not observe any effect
on the internalization of Cy3-FGF1. Quantification of the intensity
of Cy3-FGF1 staining in cells depleted of flotillins compared to
non-depleted cells revealed that the Cy3-FGF1 uptake was not
significantly changed in any case (Fig. 6C). Moreover, no colo-
calization between Cy3-FGF1 and flotillin 1 or 2 were detected.
Taken together, the findings indicate that flotillin 1 and 2 are not
key players in the endocytic machinery responsible for FGFR1 and
FGFR3 internalization in U2OS cells.
It is possible that the clathrin-independent FGFR3 endocytosis
could be a product of several pathways. We therefore examined
internalization of Cy3-FGF1 upon co-expression of dominant
negative Arf6 and Cdc42 (Fig. 6D) and co-expression of dominant
negative Arf6 and Cdc42 together with transfection with siRNA
directed against Flotillin1 and 2 (Fig. 6E). Internalized Cy3-FGF1
was observed in any case and quantification of the intensity of the
Cy3-FGF1 staining revealed that the Cy3-FGF1 uptake was not
significantly changed compared to control cells (Fig. 6F). Taken
together the data indicate that FGFR3 does not utilize any of the
well-known clathrin-and dynamin-independent endocytic path-
ways that have been described to date.
Signalling from FGFR1 and FGFR3 upon disruption of
endocytosis
ToexaminehowendocytosiscontrolsFGFRsignalling,westudied
FGFR turnover and signalling in FGFR1 and FGFR3 cells that
have been depleted of CHC by oligo-based siRNA. The cells were
serum-starved for 4 to 6 hours and then stimulated with FGF1 for
different periods of time in the presence of cycloheximide. Cyclo-
heximide was added to prevent the appearance of newly synthesized
receptors.Thecellswerethenlysedandsubjectedtoimmunoblotting
with indicated antibodies followed by quantification (Fig. 7A,B,C).
As seen in Fig. 7A and C, the bands corresponding to FGFR1
in CHC depleted cells were more stable over time than those
Figure 6. The effect of flotillin 1 and 2 depletion on endocytosis of FGF1 in cells expressing FGFR1 or FGFR3. (A) U2OS cells stably
expressing FGFR1 or FGFR3 were transfected with siRNA oligos targeting flotillin 1 and flotillin 2 or a non-targeting siRNA control (scr) as describedi n
Materials and Methods. The level of knockdown was assessed in every experiment by Western blotting using mouse anti-flotillin 1 and mouse anti-
flotillin 2 antibodies. Anti-c-tubulin antibody was used as a loading control. One representative Western blot is shown. The bands corresponding to
flotillin 1 and flotillin 2 were quantified and knockdown efficiency is presented in the histogram as percentage of non-targeting siRNA control (scr).
The histogram represents the mean +s.d. of 12 (for flotillin 1) and 7 (for flotillin 2) independent experiments. (B) U2OS cells stably expressing FGFR1 or
FGFR3 were transfected with siRNA oligos targeting flotillin 1 and 2 or a non-targeting siRNA control (scr). The cells were then incubated for 20
minutes at 37uC with Cy3-FGF1 and 50 U/ml heparin. The cells were stained with rabbit anti-flotillin 1 antibody or rabbit anti-flotillin 2 antibody and
examined with confocal microscopy. Bar, 5 mm. (C) The uptake of Cy3-FGF1 was measured as Cy3 intensity in non-depleted and flotillin 1 and 2
depleted cells treated as described in B. The mean intensity of Cy3 in flotillin 1 and 2 depleted cells is presented in the histogram as the percentage of
Cy3 intensity in non-depleted cells. The histogram represents the mean +s.d. of four independent experiments and 67–138 cells were quantified in
each case in each experiment. Confocal scanning was performed with identical settings. (D) U2OS cells stably transfected with FGFR1 or FGFR3 were
co-transfected with HA-tagged Arf6 T27N and EGFP-Cdc42 N17 and incubated with Cy3-FGF1 and 50 U/ml heparin at 37uC for 20 min. The cells were
then fixed, stained with anti-HA antibody and examined with confocal microscopy. Bar, 5 mm. (E) U2OS cells stably expressing FGFR1 or FGFR3 were
transfected with siRNA oligos targeting flotillin 1 and 2 or a non-targeting siRNA control (scr). The cells were then transfected with HA-tagged Arf6
T27N and EGFP-Cdc42 N17 and incubated for 20 minutes at 37uC with Cy3-FGF1 and 50 U/ml heparin. The cells were fixed, stained with anti-HA
antibody and examined with confocal microscopy. Bar, 5 mm. (F) The uptake of Cy3-FGF1 was measured as Cy3 intensity in untransfected or co-
transfected cells (Arf6 T27N and Cdc42 N17) or in the case of flotillin knockdown as untransfected scr cells or co-transfected (Arf6 T27N and Cdc42
N17), flotillin1/2 siRNA cells. The mean intensities of Cy3 in transfected cells are presented in the histograms as the percentage of Cy3 intensity in
untransfected cells. The histogram represents the mean +s.d. of three independent experiments and 32–52 cells were quantified in each case in each
experiment. Confocal scanning was performed with identical settings.
doi:10.1371/journal.pone.0021708.g006
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FGFR1 is degraded more slowly in cells depleted of clathrin. Also
the bands corresponding to phosphorylated FGFR1 and the
phosphorylated downstream effectors such as FRS2a (fibroblast
growth factor receptor substrate 2a) and MAPK p42/p44 were
more stable over time in clathrin-depleted cells than in non-
depleted cells. Taken together, these results indicate that FGFR1
signalling is prolonged upon CHC depletion due to decreased
degradation of FGFR1. In FGFR3 cells, the differences between
scrambled siRNA transfected and CHC siRNA transfected cells
were not as pronounced as in the case of FGFR1 (Fig. 7B,C). The
bands corresponding to FGFR3 in cells depleted of clathrin were
somewhat stronger over time than in non-depleted cells.
Interestingly, the intensities of the bands corresponding to
phosphorylated FGFR1, FRS2a and MAPK p42/44 peaked at
later time points in clathrin-depleted FGFR1 cells compared to
non-depleted FGFR1 cells. For example, the intensities of the
bands corresponding to phosphorylated MAPK p42/44 peaked
30–60 minutes after addition of FGF1 in CHC-depleted FGFR1
cells whereas in non-depleted FGFR1 cells the bands correspond-
ing to phosphorylated MAPK p42/44 peaked already 5 minutes
after addition of FGF1. In the case of FGFR3, the bands cor-
responding to phosphorylated FRS2a and MAPK p42/44 were
only slightly stronger at earlier time points in non-depleted cells
than in CHC-depleted cells. This is in accordance with the ob-
servation that endocytosis of FGFR3 is only partly dependent on
clathrin. These results indicate that clathrin-mediated endocytosis
is required for efficient activation of certain FGFR1 downstream
signalling molecules, but not for FGFR3.
Discussion
Internalization of signalling receptors from the cell surface is the
first step in a series of events that influence the signalling out-
put. We have here demonstrated that internalization of FGFR1
and FGFR3 is dependent on different molecular machineries.
Internalization of FGFR1 was severely reduced when cells were
depleted of clathrin or by expression of a dominant negative
mutant of dynamin. This indicates that when bound to FGFR1,
FGF1 is mainly endocytosed through clathrin mediated endocy-
tosis. Internalization of FGFR3 was only partly inhibited by
clathrin depletion. Expression of a dominant negative construct of
dynamin induced accumulation of FGFR3 in defined areas at the
cell surface and reduced, but did not abolish, the amount of
internalized receptor. These results suggest that FGFR3 is
internalized via both clathrin-dependent and clathrin-independent
endocytosis. Depletion of clathrin decreased the degradation of
FGFR1 due to delayed transport to the lysosomes. In contrast,
FGFR3 degradation was only slightly delayed upon depletion of
clathrin. Moreover, full, immediate activation of FGFR1 signalling
required clathrin-mediated endocytosis whereas activation of FGFR3
signalling was only slightly delayed upon clathrin-depletion. As
FGFR3 is endocytosed with a lower rate than FGFR1, it implies
that the clathrin-independent endocytic component of FGFR3
internalization is a slower process than the classic clathrin-mediated
endocytosis.
It is not clear which molecules are mediating the clathrin-
independent endocytosis of FGFR3. According to the classification
of non-clathrin endocytosis [8,9] the Cdc42 (GEEK/CLIC)-, the
flotillin- and the Arf6-mediated pathways are independent of
dynamin. We therefore examined whether interfering with any of
these proteins affected FGFR endocytosis. However, the uptake of
FGF1 in FGFR3 or FGFR1 cells was not significantly altered upon
expressing of dominant negative mutants or depletion of cells of
these proteins. Arf6, Cdc42 and flotillin seem not to be major
players in FGFR3 endocytosis in the U2OS cells. Probably, other
clathrin- and dynamin independent pathways exist [10,12] and
FGFR3 may be a cargo protein in such a new uncharacterized
endocytic pathway.
It should be kept in mind that interfering with the endocytic
machinery may activate new pathways or cause upregulation of
such ones that normally play only a minor role [36]. Here, we
have compared endocytosis of FGFR1 and FGFR3 in the same
cellular system and under the same conditions using U2OS cells
stably transfected with either receptor. It is likely that the up-
regulation or activation of other endocytic pathways would be
similar in both cases and thus, that the observed clathrin-
independent endocytosis of FGFR3 is not due to such effects. It
should also be noted that the rate of FGFR1 endocytosis during
clathrin knockdown is similar to that of FGFR3. It can therefore
not be excluded that a minor fraction of FGFR1 could also be
endocytosed through a clathrin independent mechanism.
Although we analyzed several independent clones of stably
transfected U2OS cells, the FGFR1 cells generally provided about
three times as many cell surface binding-sites for FGF1 as the
FGFR3 cells (Fig. S3). The amount of the receptors at the cell
surface may influence the internalization in several ways. Firstly, a
larger number of receptors at the cell surface may induce more
clathrin-independent internalization of receptors due to saturation
of the clathrin-dependent endocytic system [37]. Even though
FGFR1 was overexpressed in the U2OS cells, FGFR1 seems to be
mainly internalized by clathrin-mediated endocytosis. Since
FGFR1 was expressed to a higher extent than FGFR3, it is not
likely that the observed clathrin-independent uptake of FGFR3
was due to overexpression and constitutive internalization of the
receptor. Secondly, it has been suggested that high concentrations
of ligand might direct the receptors to clathrin independent endo-
cytosis whereas low concentrations of ligand direct the receptor to
clathrin-mediated endocytosis [13,27]. However, we have tested
ligand concentrations from 2–100 ng/ml and clathrin-indepen-
dent uptake of FGFR3 was observed in all cases.
Depletion of clathrin decreased the degradation of FGFR1, and
prolonged its signalling properties. This probably reflects the
significant role internalization plays on receptor signalling. Cla-
thrin might also play a role in endosomal sorting and recycling
[38,39]. It is possible that the signalling from the receptors is
prolonged upon clathrin heavy chain depletion due to both
inefficient internalization and inefficient sorting to the lysosomes.
However, consistent with the observation that FGFR3 is inter-
nalized via both clathrin-dependent and clathrin-independent
endocytosis, the signalling through FGFR3 upon clathrin depletion
was much less prolonged than the signalling through FGFR1.
Figure 7. Degradation and signalling in FGFR1 and FGFR3 cells upon clathrin heavy chain depletion. U2OS cells stably expressing
FGFR1 (A) or FGFR3 (B) were transfected with siRNA oligos (100 nM) targeting CHC or a non-targeting siRNA control (scr), serum-starved for 4–
6 hours and then stimulated with the growth factor in the presence of heparin (20 U/ml) and cycloheximide (10 mg/ml) for different time points. Cells
were lysed, and the cellular material was analyzed by SDS-PAGE and immunoblotting using following antibodies: anti CHC, anti-FGFR1/anti-FGFR3,
anti-phospho-FGFR (p-FGFR), anti-phospho-FRS2a (p-FRS2a), anti-phospho-MAPK (p-MAPK) and anti-Hsp90 as a loading control. (C) The amount of
FGFR, p-FGFR, p-FRS2a and p-MAPK were expressed as a percentage with the maximum for each protein set to 1. The graph represents the mean
6s.d. of three independent experiments.
doi:10.1371/journal.pone.0021708.g007
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and activate other downstream signalling molecules than receptors
at the cell surface [1]. Here, we report prolonged signalling from
receptors that are trapped at the cell surface due to clathrin
depletion. However, full phosphorylation of FGFR and of down-
stream signalling molecules was reached at a later time point in
clathrin depleted cells than in non-depleted cells. This indicates
that endocytic trafficking is required for full activation of the
signalling pathways here examined.
The 22 FGFs and 4 FGFRs make up a large and complex
signalling system with the ability to mediate a wide spectrum of
biological effects in different types of cells. However, the various
signalling complexes mainly activate the same intracellular sig-
nalling pathways. Spatio-temporal regulation of FGFR signalling
adds diversity to the signalling system and can generate different
signalling output. We have here reported that FGFR1 and FGFR3
are endocytosed via different mechanisms and thus are dependent
on different endocytic machineries which can regulate both the
duration and the strength of their signalling. This introduces
additional diversity into the FGFR signalling system.
Knowledge of the mechanisms of internalization is important to
understand how signalling receptors and other molecules in the
plasma membrane are regulated. In the case of FGFRs such
knowledge might open up for development of treatments for
disorders associated with excess FGFR signalling.
Materials and Methods
Antibodies and reagents
The following primary antibodies were used: mouse anti-HA.11
(Covance, Nordic Biosite, Ta ¨by, Sweden); mouse anti-early
endosomal antigen (EEA) 1, mouse anti-Hsp90, mouse anti-
flotillin 1, mouse anti-flotillin 2 (BD Biosciences Transduction
Laboratories, Lexington, KY); mouse anti-CHC (RDI division of
Fitzgerald Industries, Concorde, MA); goat anti-CHC, rabbit anti-
FGFR1, rabbit anti-FGFR3 (Santa Cruz Biotechnology, Santa
Cruz, CA); rabbit anti-HA, mouse anti-Myc Tag, clone 4A6
(Millipore, Billerica, MA); mouse anti-phospho-FGFR, rabbit anti-
phospho-FRS2a (Y196), rabbit anti-MAPK (p42/p44), mouse
anti-phospho-MAPK (p42/p44), rabbit anti-Cdc42, rabbit anti-
Arf6 (Cell Signaling Technology, Danvers, MA); rabbit anti-
flotillin-2, mouse anti-c-tubulin (Sigma-Aldrich, St.Louis, MO).
Rabbit anti-Arf6 was a generous gift from Dr. J.G. Donaldson
(NIH, Bethesda, MD) and rabbit anti-flotillin-1 was a generous
gift from Dr. G. van der Goot (EPFL, Lausanne, Switzerland).
Secondary antibodies were from Jackson Immuno-Research
Laboratories (West Grove, PA). Alexa 647-Tf was from Invitrogen
(Carlsbad, CA). FGF1 was labelled with Cy3-maleimide (GE
Healthcare, Chalfont St. Giles, United Kingdom) following the
manufacturer’s procedures. FGF1 was iodinated by the Iodogen
method according to the manufacturer’s protocol (Pierce Chem-
ical, Rockford, IL). [
125I]Na was from PerkinElmer. The following
reagents were used: cycloheximide, 10% formalin solution (ap-
proximately 4% formaldehyde), heparin, Pronase E (Sigma-
Aldrich); DharmaFECT transfection reagent 1 and 2 (Dharmacon
RNA Technologies, Lafayette, CO); DOTAP, Fugene 6 (Roche
Diagnostics, Indianapolis, IN); Geneticin (G-418), Lipofectamine
RNAiMAX transfection reagent, Hoechst 33342 (Invitrogen);
Mowiol (Calbiochem, San Diego, CA); DRAQ5 (Biostatus
Limited, Leicestershire, United Kingdom); RNeasy plus mini kit,
QuantiTect SYBR green PCR kit, QuantiTect primers (Qiagen);
iScript cDNA synthesis kit (Bio-Rad Laboratories), MatTek
35 mm glass-bottom dishes (MatTek corporations, Ashland, MA).
125I-Tf was a generous gift from Anne Grete Myrann, this institute.
Plasmids and siRNA oligos
pcDNA3-hFGFR1, pcDNA3-hFGFR2 and pcDNA3-hFGFR4
has been described previously [25]. pcDNA3-hFGFR3 was a
generous gift from Dr. A. Yayon (ProChon Biotech, Ness Ziona,
Israel). pcDNA3.1 hemagglutinin epitope (HA) tagged wild-type
and K44A mutant constructs of dynamin 1 and dynamin 2 were
a generous gift from Dr. S. L. Schmid (The Scripps Research
Institute, La Jolla, CA). pXS HA tagged Arf6 T27N [40] was a
generous gift from Dr. J. G. Donaldson (NIH, Bethesda, MD).
pEGFP-C1-Cdc42 N17 [41] was a generous gift from Dr. F.
Sanchez-Madrid (Universidad Autonoma de Madrid, Madrid,
Spain). Vector-based siRNA against CHC has been described
previously [42]. siRNA oligos targeting CHC (targeting sequence:
5-GCAATGAGCTGTTTGAAGA-3) and siRNA targeting Arf6
(targeting sequence: 5-AAGGTCTCATCTTCGTAGTGG-3)
were purchased from MWG Biotech (Ebersberg, Germany) and
have been described previously [6,43]. siRNA oligos targeting
flotillin 1 (targeting sequence: 5-GCAGAGAAGUCCCAACUA-
AUU-3), flotillin 2 (targeting sequence: 5-GAGGUUGUGCAG-
CGCAAUU-3) Cdc42 (targeting sequence: 5-CTCCTGATAT-
CCTACACAA-3), and ON-TARGETplus siCONTROL siRNA
were purchased from Dharmacon RNA Technologies. The siRNA
oligostargeting flotillin 1 and 2 have been described previously [35].
Cells and transfection
Transient expression of the different constructs was performed
by transfecting cells with the plasmid DNA using Fugene 6
transfection reagent according to the manufacturer’s protocol.
Cells were seeded into plates the day preceding the transfection
and experiments were performed 16–24 hours after transfection.
For the vector-based knockdown of clathrin, the cells were
transfected with vector-based siRNA against CHC for 96 hours.
Oligo-based knockdown was performed using DharmaFECT
transfection reagent or Lipofectamine RNAiMAX transfection
reagent according to the manufacturer’s protocol. Experiments
were performed 48 hours (Arf6 and Cdc42 siRNA) or 72 hours
(CHC siRNA and flotillin 1 and 2) after transfection. DOTAP
liposomal transfection reagent was used according to the manu-
facturer’s protocol to obtain U2OS cells stably expressing FGFR3.
Clones were selected with 1 mg/ml geneticin. Clones were chosen
based on their receptor expression level analyzed by immunoflu-
orescence and immunoblotting. U2OS cells stably expressing
FGFR1 have been described previously [20]. The cells were
propagated in DMEM, supplemented with 10% fetal bovine
serum, 100 U/ml penicillin and 100 mg/ml streptomycin in a 5%
CO2 atmosphere at 37uC. In addition, 0.2–1 mg/ml geneticin was
added to the growth media of stably transfected U2OS cells.
RNA isolation, cDNA synthesis and quantitative real-time
polymerase reaction (qRT-PCR)
Total RNA was isolated from cell lysate using RNeasy plus mini
kit and the QIAcube robot (Qiagen) according to the manufac-
turer’s protocol. Then 0.5 mg of RNA was used for cDNA
synthesis using iScript cDNA synthesis kit. Quantitative real-time
PCR was performed using QuantiTect SYBR Green PCR kit,
cDNA template and the following QuantiTect primers: Arf6
(QT01681582), Cdc42 (QT01674442), Flotillin 1 (QT00036743),
Flotillin 2 (QT00079926) and Succinate dehydrogenase (SDHA)
(QT00059486). The qRT-PCR was run and analysed using the
Lightcycler 480 (Roche). Cycling conditions were 5 minutes at
95uC followed by 45 cycles 10 seconds at 95uC, 20 seconds at
60uC and 10 seconds at 72uC. Gene amplification was normalized
to the expression of SDHA.
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Cells grown on coverslips were incubated with 100 ng/ml Cy3-
FGF1 for 20 minutes at 37uC in the presence of 50 U/ml heparin.
The cells were fixed in 4% formaldehyde solution and mounted in
Mowiol. In some cases the cells were washed with high salt/low
pH (HSLP) buffer (2 M NaCl and 20 mM NaAc, pH 4.0) before
fixation. In some experiments the cells were in addition to Cy3-
FGF1 incubated with 5 mg/ml Alexa 647-Tf. When antibodies
were used to visualize structures within the cell, the cells were
permeabilized with 0.1% Triton X-100 and incubated with the
primary antibody for 20 minutes, washed and then incubated with
the secondary antibody coupled to a fluorophore for 20 minutes
before mounting in Mowiol. The cells were examined with a Zeiss
LSM 510 META confocal microscope (Carl Zeiss, Jena, Ger-
many). Images were prepared with Zeiss LSM Image Browser
version 3.2 (Carl Zeiss) and CorelDRAW11 (Corel, Fremont, CA).
For quantification of Cy3-FGF1 uptake, cells randomly located on
the coverslips were scanned at fixed intensity settings below pixel-
saturation and the total cellular intensity was determined using the
histogram function in the Zeiss LSM 510 Software (Carl Zeiss). All
pixel values above the background level were quantified.
Internalization of
125I-FGF1
Internalization experiments were performed on confluent cells
growing on 12-well gelatinized microtiter plates incubated for
indicated periods of time at 37uC with indicated concentrations of
125I-FGF1 in HEPES medium containing 0.2% gelatine and
20 U/ml heparin. The cells were then washed twice with ice-cold
HEPES medium and once in washing buffer (1.14 M NaCl and
10 mM NaH2PO4, pH 7.4). Surface bound
125I-FGF1 was
collected after removal with high salt/low pH (HSLP) buffer and
finally, internalized
125I-FGF1 was collected after solubilisation of
cells in 1M KOH. Radioactivity was measured with a c-counter
and the ratio of internalized to surface-localized
125I-FGF1 was
plotted as function of time.
125I-FGF1 binding experiments
125I-FGF1 saturation binding experiments were essentially per-
formed as previously published experiments [30]. The cells were
incubated for 2 hours at 4uC in HEPES medium containing
20 U/ml heparin, 0.2% gelatine and increasing concentrations of
125I-FGF1. Then, the cells were washed twice with ice-cold
HEPES and once in 1 M NaCl in PBS. Cells were solubilised in 1
M KOH and the solubilised radioactivity was measured with a
c-counter.
Internalization of
125I-Tf
Internalization experiments were performed on confluent cells
growing on 12-well gelatinized microtiter plates incubated for 2
minutes at 37uC with
125I-Tf in HEPES medium containing 0.2%
gelatine. The cells were then washed three times with ice-cold
HEPES medium and incubated 1 hour at 4uC with HEPES
medium containing 2 mg/ml pronase. After pronase treatment the
medium containing the cells was centrifuged for 2 minutes before
the radioactivity in the cell pellet (endocytosed) and in the
supernatant (surface bound) were measured with a c-counter.
Endocytosed
125I-Tf was calculated as the percentage of total cell-
associated (endocytosed and surface-bound) transferrin.
Western blot analysis of FGFR degradation
Cells transfected with CHC siRNA were serum-starved for
4–6 hours and then stimulated with 30 ng/ml FGF1 in the
presence of 10 U/ml heparin and 10 mg/ml cycloheximide for
different time points. The cells were lysed with SDS sample buffer,
scraped and sonicated. Total cell lysates were separated by SDS-
PAGE, transferred onto Immobilon-P membrane and subjected to
immunoblot analysis. The membrane was stripped and re-probed
with different antibodies. ImageQuant version 5 was used for
quantification of the intensity of the bands of interest.
Cell migration analysis
Cells were plated on 35 mm glass-bottom MatTek dishes,
transfected as described above and then observed for a period of
9–15 hours using a Biostation IM (Nikon, Melville, NY). Cells
were maintained in a 5% CO2 atmosphere at 37uC throughout
the observation period. Pictures of the cells were acquired every 10
minutes and velocity of migration was determined using the Image
J software.
Supporting Information
Figure S1 Examination of level of endogenous FGFRs in
U2OS cells. Untransfected U2OS cells (U2OS) or U2OS cells
stably expressing FGFR1 or FGFR3 (U2OS FGFR1/U2OS
FGFR3) or U2OS cells transiently transfected with FGFR2 or
FGFR4 (FGFR2/FGFR4) were lysed and the cellular material was
analyzed by SDS-PAGE and immunoblotting using the indicated
antibody.
(TIF)
Figure S2 (A) Ability of FGF1 to bind to cells depleted of
clathrin heavy chain. Binding of
125I-FGF1 (,28 000 cpm/ng)
to U2OS cells stably expressing FGFR1 or FGFR3 and depleted
of CHC by siRNA oligo-mediated knockdown was measured by
adding increasing concentrations of the labelled growth factor to
the cells at 4uC in the presence of 20 U/ml heparin and 0.2%
gelatine. After 2 hours unbound
125I-FGF1 was removed by
washing and the amount of radioactivity associated with the cells
was measured. The graph represents the mean 6s.d. of three
independent experiments with three parallels. (B) The effect of
clathrin heavy chain siRNA on endocytosis of Tf in cells
expressing FGFR1 or FGFR3. U2OS cells stably expressing
FGFR1 or FGFR3 were transfected with siRNA oligos targeting
CHC or a non-targeting siRNA control (scr), grown on gelatinized
plates and incubated with
125I-Tf and 0.2% gelatine at 37uC for 2
minutes. Internalized and surface-bound
125I-Tf were separated as
described in Materials and methods and endocytosed
125I-Tf is pre-
sented as percentage of total cell associated. The graph represents
one independent experiment with three parallels +s.d.
(TIF)
Figure S3 Ability of FGF1 to bind to cells stably
expressing FGFR1 or FGFR3. Binding of
125I-FGF1 (,20
000 cpm/ng) to U2OS cells stably expressing FGFR1 or FGFR3
was measured by adding increasing concentrations of the labelled
growth factor to the cells (approx. 300 000 cells/well) at 4uC in the
presence of 20 U/ml heparin and 0.2% gelatine. After 2 hours
unbound
125I-FGF1 was removed by washing and the amount of
radioactivity associated with the cells was measured. The number
of binding sites was calculated based on the presumption that
saturation was achieved at 25 ng/ml FGF1. The graph represents
the mean 6s.d. of two independent experiments with three
parallels.
(TIF)
Figure S4 Knockdown efficiency examined by mRNA
level. RNA isolation, cDNA synthesis and qRT-PCR were
performed as described in materials and methods. The amount of
mRNA were calculated relative to the housekeeping gene SDHA
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the mean +s.d. of two independent experiments.
(TIF)
Figure S5 Validation of disruption of Arf6 and Cdc42.
(A) U2OS cells stably expressing FGFR3 were transfected with
siRNA oligos targeting Arf6 or a non-targeting siRNA control (scr)
and monitored by imaging every 10 minutes for 9 hours in the
presence of 100 ng/ml FGF1 and 20 U/ml heparin. The velocity
of migration was quantified and the mean velocity is presented in
the histogram. The histogram represents one independent
experiment +s.d. and 39–40 cells were quantified for each
condition. (B) U2OS cells stably expressing FGFR3 were
transfected with EGFP-Cdc42 N17 and cell migration was
monitored by imaging every 10 minutes for 15 hours in the
presence of 100 ng/ml FGF1 and 20 U/ml heparin. The velocity
of migration was quantified and the mean velocity is presented in
the histogram. The histogram represents one independent experi-
ment +s.d. and 10 cells were quantified for each condition.
(TIF)
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